Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93.9Revenue $M41.1Net Margin (%)61.3Z-Score23.7
Enterprise Value $M50.7EPS $0.7Operating Margin %60.9F-Score5
P/E(ttm))4.2Cash Flow Per Share $-0.1Pre-tax Margin (%)61.1Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %0Quick Ratio18.3Cash flow > EarningsN
Price/Sales2.65-y EBITDA Growth Rate %0Current Ratio18.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)47.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)59.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M45.8ROI % (ttm)-13.4Gross Margin Increase y-yN

Gurus Latest Trades with PTIE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PTIEMario Gabelli 2014-09-30 Reduce$3.6 - $5.72
($4.32)
$ 2.06-52%Reduce -33.33%100,000
PTIEJean-Marie Eveillard 2014-06-30 Add0.01%$4.58 - $6.06
($5.28)
$ 2.06-61%Add 22.14%4,474,735
PTIEGeorge Soros 2014-06-30 Sold Out -0.01%$4.58 - $6.06
($5.28)
$ 2.06-61%Sold Out0
PTIEGeorge Soros 2014-03-31 Buy 0.01%$3.92 - $5.71
($5.03)
$ 2.06-59%New holding, 103700 sh.103,700
PTIEJean-Marie Eveillard 2014-03-31 Add0.01%$3.92 - $5.71
($5.03)
$ 2.06-59%Add 25.15%3,663,750
PTIEJean-Marie Eveillard 2013-12-31 Add0.01%$2.61 - $4.73
($3.79)
$ 2.06-46%Add 20.37%2,927,386
PTIEMario Gabelli 2013-12-31 Reduce$2.61 - $4.73
($3.79)
$ 2.06-46%Reduce -24%190,000
PTIEJean-Marie Eveillard 2013-09-30 Add$2.21 - $3.11
($2.5)
$ 2.06-18%Add 30.6%2,431,935
PTIEJean-Marie Eveillard 2013-06-30 Add0.01%$2.21 - $5.41
($3.02)
$ 2.06-32%Add 171.01%1,862,099
PTIEJean-Marie Eveillard 2013-03-31 Add$2.47 - $3.74
($3.01)
$ 2.06-32%Add 30.53%687,099
PTIEJean-Marie Eveillard 2012-12-31 Add$2.42 - $5.83
($3.66)
$ 2.06-44%Add 163.2%526,408
PTIEJean-Marie Eveillard 2012-09-30 Buy $3.57 - $5.29
($4.22)
$ 2.06-51%New holding, 200000 sh.200,000
PTIEMario Gabelli 2011-03-31 Reduce-0.04%$6.05 - $9.72
($7.13)
$ 2.06-71%Reduce -53.97%480,000
PTIEMario Gabelli 2010-09-30 Add0.02%$5.26 - $6.49
($5.76)
$ 2.06-64%Add 111.68%1,047,800
PTIERichard Perry 2010-06-30 Sold Out -0.18%$5.32 - $6.6
($5.87)
$ 2.06-65%Sold Out0
PTIEMario Gabelli 2010-06-30 Reduce-0.01%$5.32 - $6.6
($5.87)
$ 2.06-65%Reduce -50.93%495,000
PTIEDaniel Loeb 2010-03-31 Sold Out -0.53%$5.16 - $6.76
($5.82)
$ 2.06-65%Sold Out0
PTIEDaniel Loeb 2009-12-31 Buy 0.53%$4.71 - $5.77
($5.19)
$ 2.06-60%New holding, 1000000 sh.1,000,000
PTIERichard Perry 2009-12-31 Buy 0.16%$4.71 - $5.77
($5.19)
$ 2.06-60%New holding, 1000000 sh.1,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PTIE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PTIE Jean-Marie Eveillard 2014-09-305,050,83711.040.05+12.87%
PTIE Mario Gabelli 2014-09-30100,0000.220-33.33%
Premium Most recent portfolio changes are included for Premium Members only!


PTIE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROBERTSON SANFORDDirector 2013-11-06Buy50,000$3.73-44.77view
FRIEDMANN NADAVCOO 2011-10-18Sell25,000$4.44-53.6view
Sabretooth Master Fund, L.P.10% Owner 2011-10-04Sell382,000$4.59-55.12view
FRIEDMANN NADAVCOO 2011-10-04Sell25,000$4.81-57.17view
FRIEDMANN NADAVCOO 2011-09-15Sell25,000$4.89-57.87view
BARBIER REMICEO, Chairman of the Board, 10% Owner 2011-08-08Buy5,000$4.22-51.18view
Sabretooth Master Fund, L.P.10% Owner 2011-08-08Sell44,417$4.2-50.95view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-10-04Sell50,000$6.2-66.77view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-07Sell28,597$5.69-63.8view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-02Sell21,403$5.81-64.54view

Press Releases about PTIE :

    Quarterly/Annual Reports about PTIE:

    News about PTIE:

    Articles On GuruFocus.com
    Eveillard's First Eagle Increases 2 Positions Sep 11 2014 
    Morning Coffee: Real-Time Picks May 14 2014 
    Pain Therapeutics Reports Operating Results (10-K) Feb 03 2011 
    Pain Therapeutics Reports Operating Results (10-Q) Oct 29 2010 
    Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 50,000 Shares Oct 04 2010 
    Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 28,597 Shares Sep 08 2010 
    Pain Therapeutics (ptie) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 21,403 Shares Sep 02 2010 
    Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 22,391 Shares Aug 04 2010 
    Pain Therapeutics Reports Operating Results (10-Q) Jul 29 2010 
    Pain Therapeutics (PTIE) CEO and Chairman of the Board, 10% Owner Remi Barbier sells 27,243 Shares Jul 08 2010 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Dec 18 2014
    PAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 18 2014
    PAIN THERAPEUTICS INC Financials Nov 18 2014
    10-Q for Pain Therapeutics, Inc. Nov 07 2014
    PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Nov 05 2014
    Pain Therapeutics Reports Q3 2014 Financial Results Oct 30 2014
    Pain Therapeutics Reports Q3 2014 Financial Results Oct 30 2014
    Q3 2014 Pain Therapeutics Inc Earnings Release - Before Market Open Oct 30 2014
    PAIN THERAPEUTICS INC Files SEC form 8-K, Termination of a Material Definitive Agreement Oct 29 2014
    Pain Therapeutics and Durect Stung by Pfizer Move Oct 27 2014
    Pfizer (PFE) Stock Falls After Dropping Pain Drug Oct 27 2014
    Pfizer ends agreement to develop Remoxy Oct 27 2014
    [$$] Pfizer Ends Pact to Develop Remoxy Oct 27 2014
    Pain Therapeutics, Durect shares tumble after Pfizer discontinues development pact Oct 27 2014
    DURECT Provides Update on REMOXY® and POSIDUR™ Programs Oct 27 2014
    Pain Therapeutics to Regain Full Rights to REMOXY(R) Oct 27 2014
    DURECT Provides Update on REMOXY® and POSIDUR™ Programs Oct 27 2014
    PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events Oct 27 2014
    Pain Therapeutics to Regain Full Rights to REMOXY(R) Oct 27 2014
    Pain Therapeutics to Host Conference Call to Discuss Q3 2014 Financial Results Oct 23 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK